Parents pursued medical cannabis for seriously ill children despite obstacles and lack of medical guidance

Interviews with 10 parents of children with cancer or epilepsy at a Canadian hospital revealed they pursued medical cannabis out of desperation, navigated inconsistent information, and perceived it as both a medicine and a natural product.

Gibbard, Marissa et al.·CMAJ open·2021·Preliminary EvidenceQualitative Study
RTHC-03152QualitativePreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Qualitative Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Five themes emerged: 1) parents sought cannabis as a last resort for severely ill children; 2) information came from social media, industry, and other families rather than healthcare providers; 3) cannabis was viewed ambiguously as both a serious drug needing medical oversight and a safe natural product; 4) parents perceived medical benefits with few adverse effect concerns; 5) high costs and uncertain legality were barriers but did not stop use.

Key Numbers

10 interviews; 9 mothers, 1 couple; children aged 22 months to 16 years; 6 used for epilepsy, 4 for chemotherapy; 5 major themes identified

How They Did This

Qualitative study with semistructured interviews of 10 parents (9 mothers, 1 couple) of children at BC Children's Hospital oncology or palliative care clinics who used medical cannabis. Children ranged from 22 months to 16 years. Thematic analysis using qualitative description.

Why This Research Matters

Parents of seriously ill children are making medical cannabis decisions largely without professional guidance. Their reliance on social media, industry, and peer networks for information creates risks of misinformation and inappropriate use.

The Bigger Picture

The gap between parental desperation and medical knowledge creates a situation where families make complex pharmacological decisions with minimal professional support. Developing pediatric medical cannabis guidelines would help bridge this gap.

What This Study Doesn't Tell Us

Small qualitative sample (10 interviews) at one hospital. Self-selected parents willing to discuss cannabis use. Cannot generalize to all families using medical cannabis for children. Social desirability bias possible.

Questions This Raises

  • ?What would effective pediatric medical cannabis guidelines look like?
  • ?How can healthcare providers bridge the information gap without oversimplifying the evidence?

Trust & Context

Key Stat:
Parents relied on social media, industry, and peer networks rather than healthcare providers
Evidence Grade:
Qualitative study providing rich descriptive data on family decision-making, but small sample limits generalizability.
Study Age:
Published in 2021 using April-July 2019 interviews.
Original Title:
Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study.
Published In:
CMAJ open, 9(2), E563-E569 (2021)
Database ID:
RTHC-03152

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Uses interviews or focus groups to understand experiences in depth.

What do these levels mean? →

Frequently Asked Questions

Why did parents use medical cannabis for their children?

Parents described it as a last resort for severely ill children. They felt desperation and parental responsibility to try everything available. The primary reasons were epilepsy (6 children) or managing chemotherapy side effects (4 children).

Where did parents get information?

Primarily from social media, cannabis industry sources, and other families. Healthcare providers were largely absent from the information landscape, leaving parents to navigate complex decisions with potentially biased or incomplete sources.

Read More on RethinkTHC

Cite This Study

RTHC-03152·https://rethinkthc.com/research/RTHC-03152

APA

Gibbard, Marissa; Mount, Dawn; Rassekh, Shahrad R; Siden, Harold Hal. (2021). Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study.. CMAJ open, 9(2), E563-E569. https://doi.org/10.9778/cmajo.20200212

MLA

Gibbard, Marissa, et al. "Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study.." CMAJ open, 2021. https://doi.org/10.9778/cmajo.20200212

RethinkTHC

RethinkTHC Research Database. "Family attitudes about and experiences with medical cannabis..." RTHC-03152. Retrieved from https://rethinkthc.com/research/gibbard-2021-family-attitudes-about-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.